October 21, 2026
On October 6, 2026, the Departments of the Treasury, Labor, and Health and Human Services (collectively, “the Departments”) published final Transparency in Coverage (“TiC”) rules (“2026 final rules”) that amend the 2020 final TiC rules (“2020 rules”) applicable to non-grandfathered medical plans. The final rule updates the 2020 rules to improve the:
Subsequently, the Departments published FAQ 75 to further clarify the 2026 final rules.
Under the 2020 rules, group health plans and health insurance carriers must make public MRFs that disclose:
1. in-network rates;
2. out-of-network allowed amounts and billed charges; and
3. negotiated rates and historical net prices for covered prescription drugs.
While (1) and (2) above went into effect on July 1, 2022, the prescription drug MRF was delayed. In FAQ 61, the Departments announced that the enforcement deferral for the prescription drug MRF was rescinded and that additional guidance would be issued in order for plans and carriers to comply with this requirement. To date, that guidance has not been released.
In addition, the 2020 rules implemented requirements for plans and carriers to provide a price comparison tool with price estimates of all common health care items and services.
The Departments and other stakeholders identified several barriers to fully achieving the goals of the 2020 rules with respect to transparency. The 2026 final rules attempt to improve the access and usability of these files.
The 2026 rules finalize several changes to the MRF requirements. Many of these changes impact the content of the files, including organizing the files by provider network (instead of plan) and removing provider/service combinations that are unlikely to occur. Technical guidance for new schemas for the in-networks and out-of-network MRFs will be released in February 2027.
Specifically, the final rule amends the MRF requirements by modifying the required data elements of the in-network rate and out-of-network allowed amount MRFs, requiring additional Utilization, Taxonomy, and Text files, and standardizing MRF formats, among other things. Schema version 1.0 of the new Utilization, Taxonomy, and Text files will be released on or around June 1, 2027 (Phase 2). Many of these changes will be handled by the service provider who builds and develops these files.
However, there are some significant changes that plan sponsors should be aware of:
What about the prescription drug (“Rx”) MRFs?
There is a third MRF required under the TiC rules for pharmacy benefits. While there is some guidance regarding the Rx MRF in the 2026 final rule (e.g., it will remain on a monthly update schedule), the Departments are still considering comments received on the request for information regarding this requirement.
On October 7, 2026, the Departments issued FAQ 75 providing further insight on the new MRF requirements and information on the Rx MRF. According to the guidance, the Departments will begin development of the schema version for the Rx file in November 2026 and expect to release the final version in May 2027. Plans and carrier will be expected to publish the Rx MRF in December 2027, and monthly thereafter. Further guidance is expected. According to the final rule, “The Departments plan to begin working to implement the prescription drug file in short order.”
The 2020 rules require group health plans (and health insurance carriers) to make available cost-sharing information to participants and beneficiaries through an online self-service tool or paper, upon request. This information must be provided with certain notices that include certain explanatory information and include the limitations on the information disclosed.
Under the 2026 rules:
These changes take effect for plan years beginning on or after January 1, 2027.
With respect to the obligations described above:
While the amendments substantially change the data required to be included in MRFs, the changes are primarily technical in nature and will generally be implemented by carriers, TPAs, or other vendors who are contractually responsible for maintaining TiC disclosures. In addition, service providers will need to support requests for pricing information via telephone.
Employers with fully insured plans should:
Employers with self-funded (including level funded) plans should:
In addition, all plans should await further guidance on the prescription drug MRF.
This document is designed to highlight various employee benefit matters of general interest to our readers. It is not intended to interpret laws or regulations, or to address specific client situations. You should not act or rely
on any information contained herein without seeking the advice of an attorney or tax professional. © My Benefit Advisor. All Rights Reserved. CA Insurance License #0G33244
Additional Info
Categories
Our Advisors offer in-depth analysis and are ready to help you successfully navigate employee benefits and health insurance.
Our website uses cookies. Click here to view our privacy policy.